Sylvia A. Luykx‐de Bakker

Maturation of Dendritic Cells Accompanies High-Efficiency Gene Transfer by a CD40-Targeted Adenoviral Vector

Bryan Tillman, Tanja D. de Gruijl, Sylvia A. Luykx‐de Bakker et al. · The Journal of Immunology · 1999 · 189 citations · Full text

Life Sciences, Immunology, Gene Delivery +15

Platelet doubling after the first azacitidine cycle is a promising predictor for response in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML) patients in the Dutch azacitidine compassionate named patient programme

Lieke H. van der Helm, Canan Alhan, Pierre W. Wijermans et al. · British Journal of Haematology · 2011 · 106 citations · Full text

Medicine, Hematology, Pharmacology +11

Prolonged Maturation and Enhanced Transduction of Dendritic Cells Migrated from Human Skin Explants After In Situ Delivery of CD40-Targeted Adenoviral Vectors

Tanja D. de Gruijl, Sylvia A. Luykx‐de Bakker, Bryan Tillman et al. · The Journal of Immunology · 2002 · 65 citations · Full text

Pharmacy, Immunology, Oncology +17

Prolonged Neoadjuvant Chemotherapy with GM-CSF in Locally Advanced Breast Cancer

Aafke H. Honkoop, Sylvia A. Luykx‐de Bakker, Klaas Hoekman et al. · The Oncologist · 1999 · 44 citations · Full text

Medicine, Oncology, Pharmacology +17

Extended neoadjuvant chemotherapy in locally advanced breast cancer combined with GM-CSF

Herbert M. Pinedo, Jan Buter, Sylvia A. Luykx‐de Bakker et al. · European Journal of Cancer · 2003 · 37 citations

Medicine, Oncology, Breast Oncology +12